Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Selective COX-2 inhibitors under development at Merck Frosst

Dec. 16, 1997

Diphosphonate antiarthritic agent developed at Toray

Dec. 12, 1997

Antiinflammatory and COX-2-inhibitory effects reported for rutaecarpine

Dec. 8, 1997

Preclinical results reported for JTE-522, a selective COX-2 inhibitor

Dec. 5, 1997

FR-173657 effective in models of kinin-dependent inflammation

Dec. 5, 1997

Active principle of herbal medicine with immunomodulating effects

Dec. 4, 1997

Plant-derived biflavonoid with antiinflammatory activity

Dec. 4, 1997

Results of IDEC-151/SB-217969 phase I trial reported

Dec. 4, 1997

S-2474: antiarthritic agent with dual NSAID/DMARD profile

Dec. 4, 1997

Amarillo reports positive phase II data in Sjogren's syndrome trial

Dec. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...